The emerging therapy of the medication represents a major breakthrough in the handling of type 2 diabetes. Different to existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide306682.idblogmaker.com/40709210/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment